Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2017

01-04-2017 | Letter to the Editor

Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate

Authors: Christian Arranto, Alexandar Tzankov, Jörg Halter

Published in: Annals of Hematology | Issue 4/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Facchetti F, Jones D, Petrella T (2008) Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Hazzis NL et al (eds) WHO classification of tumors of Haematopoietic and lymphoid tissues. IARC press, Lyon, pp. 145–147
2.
3.
Pagano L, Valentini CG, Pulsoni A et al (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98:239–246CrossRefPubMedPubMedCentral
4.
Dalle S, Beylot-Barry M, Bagot M et al (2010) Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 162:74–79CrossRefPubMed
Metadata
Title
Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
Authors
Christian Arranto
Alexandar Tzankov
Jörg Halter
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2907-4

Other articles of this Issue 4/2017

Annals of Hematology 4/2017 Go to the issue

Review Article

Managing patients with myelofibrosis and low platelet counts

Original Article

Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy

Letter to the Editor

Resistance to arsenic trioxide and retinoic acid therapy in acute promyelocytic leukemia

Review Article

Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion

Letter to the Editor

Severe hepatitis B virus reactivation related to ibrutinib monotherapy

Original Article

Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits